glp-1 news november 5 2025 When Joshua Hunt (@viajoshhunt) started Ozempic in April 2025, the weekly dose of the agonist semaglutide transformed him. This past March, when he decided to stop, his cravings returned — for Harvard Medical School Researcher Wins

Over 72 weeks, participants without type 2 diabetes achieved the following weight loss results : 5 mg dose: 16.0% average body weight reduction 10 mg dose: 21.4% average body weight reduction 15 mg dose: 22.5% average body weight reduction Placebo: 2.4% average body weight reduction At the highest dose, 92.7% of participants achieved at least 5% weight loss, 84.4% achieved at least 10%, 73.6% achieved at least 15%, 56.1% achieved at least 20%, and 38.7% achieved at least 25% weight loss

Only when Daughaday et al

One patient out of four with newly diagnosed erectile dysfunction is a young manworrisome picture from the everyday clinical practice

Mechanism of Action BPC-157: Acts by promoting angiogenesis, stimulating growth factor production, and activating pathways crucial for cell migration and repair, such as the FAK-paxillin axis